CONCERT PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2022.
  • Concert Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$29.6M, a 10.5% decline year-over-year.
  • Concert Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$124M, a 88.1% decline year-over-year.
  • Concert Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$77.5M, a 6.69% decline from 2020.
  • Concert Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$72.6M, a 8.06% increase from 2019.
  • Concert Pharmaceuticals, Inc. annual Operating Income (Loss) for 2019 was -$79M, a 42.2% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$124M -$29.6M -$2.81M -10.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$121M -$25.7M -$31.9M -513% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$89.6M -$36M -$12M -50.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$77.5M -$33M -$11.4M -53.2% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-03
Q3 2021 -$66.1M -$26.8M -$7.44M -38.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$58.6M $6.22M +$19.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$78M -$24M -$5.33M -28.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$72.6M -$21.5M -$551K -2.63% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$72.1M -$19.4M -$1.12M -6.12% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$71M -$13.1M +$6.29M +32.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$77.3M -$18.7M +$1.74M +8.55% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$79M -$21M -$890K -4.44% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$78.1M -$18.2M -$903K -5.21% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$77.2M -$19.4M -$5.05M -35.1% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$72.2M -$20.4M -$16.6M -436% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$55.6M -$20.1M -$7.33M -57.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$48.3M -$17.3M -$149M -113% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $101M -$14.4M -$1.4M -10.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $102M -$3.81M +$9.66M +71.7% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 $92.6M -$12.7M -$585K -4.81% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $93.2M $132M +$143M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$50.1M -$13M +$596K +4.39% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$50.7M -$13.5M +$504K +3.61% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$51.2M -$12.2M -$12.8M -1933% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$38.4M -$11.5M -$2.77M -31.9% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$35.6M -$13.6M -$55.3M -133% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 $19.7M -$14M -$5.1M -57.5% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 $24.8M $663K +$9.41M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 $15.4M -$8.69M -$1.09M -14.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 $16.5M $41.7M +$49.4M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$33M -$8.87M -$2.35M -36.1% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$30.6M -$8.75M -$3.17M -56.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-01
Q3 2014 -$27.4M -$7.61M -$492K -6.91% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-01
Q2 2014 -$26.9M -$7.73M -$17.1M -182% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-01
Q1 2014 -$9.8M -$6.52M -$5.39M -477% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-01
Q4 2013 -$4.41M -$5.58M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 -$7.12M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 $9.42M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 -$1.13M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.